Biohaven BHVN
NYSE BHVN
$15.69 -0.17 (-1.07%)
As of: Sep 4, 2026 · 3:59 PM EDT

Biohaven (BHVN) Change in Account Payables (2021 - 2026)

Biohaven (BHVN) posted Change in Account Payables of -$1.2 million for Q1 2026, up 79.12% sequentially from -$5.8 million in Q4 2025, and down 1441.76% YoY from $91000.0 in Q1 2025.

Analysis

Biohaven (BHVN) Change in Account Payables (2021 - 2026) Analysis & Trends

Biohaven has reported Change in Account Payables for 6 years, with the latest figure at -$1.2 million in Q1 2026.

  • Quarterly Change in Account Payables fell 1441.76% year-over-year to -$1.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$7.7 million (up 57.85% YoY) and the FY2025 annual result came in at -$6.4 million, down 999.44% from the prior year.
  • Change in Account Payables climbed to -$1.2 million in Q1 2026 per BHVN's latest filing, from -$5.8 million in the prior quarter.
  • Over five years, Change in Account Payables peaked at $19.1 million in Q1 2024 and troughed at -$19.1 million in Q2 2024.
  • A 5-year average of $229705.9 and a median of -$325000.0 in 2022 frame the typical range for Change in Account Payables.
  • The sharpest annual moves came in 2024 and 2026: Change in Account Payables soared 408.02% in 2024, then slumped 1441.76% in 2026.
  • Over 5 years, Change in Account Payables stood at $6.0 million in 2022, then increased by 1.51% to $6.1 million in 2023, then sank by 128.29% to -$1.7 million in 2024, then plunged by 240.99% to -$5.8 million in 2025, then soared by 79.12% to -$1.2 million in 2026.
  • According to Business Quant data, Change in Account Payables over the past three periods registered -$1.2 million, -$5.8 million, and -$2.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -66.70 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -8.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 5.03 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 37.53 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Biohaven 2.37 Bn 2.10 Bn - 1.69 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.69 Mn
Mar 31, 2026 -1.22 Mn
Dec 31, 2025 -5.85 Mn
Sep 30, 2025 -2.14 Mn
Jun 30, 2025 1.51 Mn
Mar 31, 2025 91,000.00
Dec 31, 2024 -1.72 Mn
Sep 30, 2024 2.49 Mn
Jun 30, 2024 -19.13 Mn
Mar 31, 2024 19.07 Mn
Dec 31, 2023 6.06 Mn
Sep 30, 2023 -2.52 Mn
Jun 30, 2023 -2.42 Mn
Mar 31, 2023 3.75 Mn
Dec 31, 2022 5.97 Mn
Sep 30, 2022 -1.65 Mn
Jun 30, 2022 -325,000.00
Mar 31, 2022 1.93 Mn
Dec 31, 2021 -2.48 Mn